M. García-Vázquez

A new clinical tool to predict outcome in early-stage melanoma patients

M. Boyano, J. Gardeazabal, J. L. Díaz-Ramón, 2019, bioRxiv.

Cyclosporin A Upmodulates the α-Subunit of the Interleukin-2 Receptor and the Metastatic Ability of Murine B16F10 Melanoma Cells

M. Boyano, A. Alvarez, M. García-Vázquez, 1999, Invasion and Metastasis.

Serum markers improve current prediction of metastasis development in early‐stage melanoma patients: a machine learning‐based study

M. Boyano, J. Gardeazabal, J. L. Díaz-Ramón, 2020, Molecular oncology.

Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients withelanoma

M. Boyano, J. Gardeazabal, J. Bilbao, 2000, British Journal of Cancer.

Analysis of Biological Properties of Human Adult Mesenchymal Stem Cells and Their Effect on Mouse Hind Limb Ischemia

I. García-Alonso, B. Herrero de la Parte, M. Morales, 2019, Journal of Vascular Research.

Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I–II early‐stage melanoma

I. M. de la Fuente, M. Boyano, J. Gardeazabal, 2016, International journal of cancer.

Serum-soluble IL-2 receptor and IL-6 levels in patients with melanoma.

M. Boyano, J. Gardeazabal, J. Díaz-Pérez, 1997, Oncology.

Interleukin-2 enhances the growth of human melanoma cells derived form primary but not from metastatic tumours.

M. Boyano, J. Gardeazabal, J. L. Díaz-Ramón, 2000, European Cytokine Network.